PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer.
The co-inhibitory receptor Programmed Death-1 (PD-1) curtails immune responses and prevent autoimmunity, however, tumors exploit this pathway to escape from immune destruction. The co-stimulatory receptor OX40 is upregulated on T cells following activation and increases their clonal expansion, survi...
Saved in:
| Main Authors: | Zhiqiang Guo, Xin Wang, Dali Cheng, Zhijun Xia, Meng Luan, Shulan Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089350&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
by: Dawei Cui, et al.
Published: (2019-01-01) -
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
by: Xiaoling Zhou, et al.
Published: (2022-01-01) -
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
by: Valenzuela F, et al.
Published: (2025-05-01) -
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives
by: Alba Guglielmo, et al.
Published: (2025-05-01) -
Mitigating cardiac allograft vasculopathy in a murine model via CD40-TRAF6 blockade and cyclosporin A synergy
by: Yajun Huang, et al.
Published: (2025-07-01)